Bangladesh vs Nigeria: The number of people with susceptibility test result for rifampicin
Bangladesh
82,924
in 2021
Nigeria
117,519
in 2021
Bangladesh rank
7th
Nigeria rank
5th
The number of people with susceptibility test result for rifampicin over time
- Bangladesh
- Nigeria
How they compare
Nigeria currently reports 117,519 against 82,924 in Bangladesh, a difference of 34,595.
That makes Nigeria's figure about 1.4 times Bangladesh's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Bangladesh ahead.
Bangladesh ranks 7th and Nigeria ranks 5th of 155 countries.
Across the 2 decades both report, Bangladesh averaged higher in 1 and Nigeria in 1.
Head to head by decade
| Decade | Bangladesh | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 39,340 | 37,878 | 1,463 | Bangladesh |
| 2020s | 65,400 | 91,529 | 26,128 | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bangladesh or Nigeria?
- Nigeria, at 117,519 against 82,924 in Bangladesh as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bangladesh and Nigeria?
- 34,595, with Nigeria ahead.
- How many years of comparable data are there for Bangladesh and Nigeria?
- 5 years are reported by both, from 2017 to 2021.
- How do Bangladesh and Nigeria rank globally for the number of people with susceptibility test result for rifampicin?
- Bangladesh ranks 7th and Nigeria ranks 5th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.